[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607587":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":55,"collaborators":25,"id":59,"slug":25,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":60,"sex":66,"minAge":67,"maxAge":25,"enrollmentInfo":68,"targetDuration":25,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":78,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"University Tunis El Manar","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ginger group","ACTIVE_COMPARATOR","Patients will receive 800 mg of oral ginger 2 hours before laparoscopic cholecystectomy",[13],"Drug: Ginger",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo group","PLACEBO_COMPARATOR","Patients will receive an oral placebo capsule identical in appearance to ginger, administered 2 hours before laparoscopic cholecystectomy",[19],"Drug: Placebo",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DRUG","Ginger",[9],null,{"type":22,"name":27,"description":17,"armGroupLabels":28,"otherNames":25},"Placebo",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Ibtissem BEN TALEB, M.D.","CONTACT","+216 23 133 748","ibtissem.bentaleb@fmt.utm.tn",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Mohamed Taher Maamouri University Hospital","RECRUITING","Nabeul","Nabeul Governorate","8000","Tunisia",{"type":44,"coordinates":45},"Point",[46,47],10.73763,36.45606,{"lat":47,"lon":46},[50,51],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},{"name":52,"role":32,"phone":53,"phoneExt":25,"email":54},"Mechaal BEN ALI, M.D.","+216 98 657 034","mechaal_benali@yahoo.fr",{"type":56,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Ben Taleb Ibtissem","Assistant Professor in Anesthesiology and Intensive Care","100607587",false,"NCT07190495","Ginger to Prevent Nausea and Vomiting After Laparoscopic Cholecystectomy","Preoperative Ginger for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy: A Double-Blind Randomized Controlled Trial","GINGER-PONV","Inclusion Criteria:\n\n* Age ≥ 18 years.\n* Scheduled for elective laparoscopic cholecystectomy under general anesthesia.\n* American Society of Anesthesiologists (ASA) physical status I-III.\n* Able to understand the study procedures and provide written informed consent.\n\nExclusion Criteria:\n\n* Known allergy or hypersensitivity to ginger\n* Documented history of bleeding disorders or current treatment with anticoagulant agents\n* History of severe postoperative nausea and vomiting or an Apfel score of 4\n* Administration of antiemetic drugs or corticosteroids during the preoperative period\n* Pregnancy or breastfeeding\n* Active gastrointestinal or liver disease","ALL","18 Years",{"count":69,"type":70},102,"ESTIMATED","INTERVENTIONAL",[73],"PHASE4","This study aims to evaluate whether preoperative oral administration of ginger (800 mg, given 2 hours before surgery) reduces the incidence and severity of postoperative nausea and vomiting (PONV) within the first 24 hours after laparoscopic cholecystectomy.",[76,77],"Postoperative Nausea and Vomiting","Laparoscopic Cholecystectomy",[23,76,77],"2026-04-27",{"date":81,"type":82},"2026-04-28","ACTUAL",{"date":84,"type":82},"2025-07-05",{"date":86,"type":70},"2026-12",{"name":5,"class":6},1]